THE SOCIAL FINANCIAL LOAD OF OPPORTUNISTIC SCREENING OF BREAST CANCER
The study was carried out concerning complex evaluation of financial load of opportunistic screening of breast cancer. The data of established cases of breast cancer and stages of disease are taken from collections "The state of oncologic care in Russia" 2014, 2015 and 2016. The financial expenses for implementation of analog mammography, sonography and physician's examination are taken from "The territorial tariff agreement 2014". The evaluation of X-ray finds was implemented using categories BI-RADS (Breast Imaging Reporting and Data System) proposed by the American College of Radiology. During 2014, in the Primorskiy Krai 40,825 of diagnostic and 50,824 cases of preventive mammography were implemented. In 2015 43,196 diagnostic and 58,567 preventive examinations and in 2016 47,359 diagnostic and 53 973 preventive examinations were implemented correspondingly. According the Foundation of mandatory medical insurance, the price of analog mammography made up to 292 rubles. The social financial load of diagnostic of a single case of breast cancer at stage T1 made up to 96,367 rubles in 2014, 90,966 rubles in 2015 and 73,303 rubles in 2016 correspondingly. The analysis of detection of breast cancer at early stage T1 and financial costs of early diagnostic demonstrated a distinct trend of decreasing of financial load at diagnostic of a single case of breast cancer of T1 during 2014-2016 at the expense of amelioration of quality of description of picture and training of radiologists. The model was proposed to form groups of higher risk with subsequent detailed examination and implementation of opportunistic screening in the group of common level of risk of development of breast cancer as a most perspective and less unprofitable one.
About the authorsApanasevich Vladimir I.
Kaprin A.D., Starinskiy V.V., Petrova G.V., eds. Status of oncological care for the population of Russia in 2016 [Sostoyanie onkologicheskoy pomoshchi naseleniyu Rossii v 2016 godu]. Moscow; 2017. (in Russian)
Mariotto A., Etzioni R., Hurlbert M., Penberthy L., Mayer M. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol. Biomarkers Prev. 2017; 26(6): 809-15.
Health Quality Ontario. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment. Ont. Health. Technol. Assess Ser. 2016; 16(15): 1-71.
Wadasadawala T., Kannan S., Gudi S., Rishi A., Budrukkar A., Parmar V., et al. Predicting loco-regional recurrence risk in T1,T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram. Indian J. Cancer. 2017; 54(1): 352-7.
Gray E., Donten A., Karssemeijer N., van Gils C., Evans D.G., Astley S., et al. Value Health. Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis. Value Health. 2017; 20(8): 1100-9.
Komarova L.E. Screening mammography of breast cancer. Pros and cons? Sibirskiy onkologicheskiy zhurnal. 2008; (Suppl. 2): 2-14 (in Russian)
Kolyadina I.V., Poddubnaya I.V., Komov D.V. Breast cancer screening: world experience and perspectives. Rossiyskiy onkologicheskiy zhurnal. 2015; 20(1): 42-6. (in Russian)
Szynglarewicz B., Matkowski R. Ductal carcinomas in situ and invasive cancers detected on screening mammography: Cost-effectiveness of initial and subsequent rounds of population-based program 2007-2014. Adv. Clin. Exp. Med. 2017; 26(2): 259-62.
Kaprin A.D., Starinskiy V.V., Petrova G.V., eds. Status of Oncological Care for the Population of Russia in 2014 [Sostoyanie onkologicheskoy pomoshchi naseleniyu Rossii v 2014 godu]. Moscow; 2015. (in Russian)
Kaprin A.D., Starinskiy V.V., Petrova G.V., eds. Status of Oncological Care for the Population of Russia in 2015 [Sostoyanie onkologicheskoy pomoshchi naseleniyu Rossii v 2015 godu]. Moscow; 2016. (in Russian)
Territorial tariff agreement for 2014. Available at: http://www.omspk.ru/upload/iblock/a75/dopcogl%20N17_tts_2014_ot_13.02.15.doc (in Russian)
Mordvinov Yu.P., Apanasevich V.I., Boltaev Yu.Yu. Possibilities of preoperative diagnosis of sclerosing adenosis of the breast. Tikhookeanskiy meditsinskiy zhurnal. 2017; (1): 58-61. (in Russian)
Order DZAPK №129-0 «On the conduct of screening activities for early detection of cancer» from 02.03.2015. Available at: Available at: http://docs.cntd.ru/document/428540802 (in Russian)
Hanley J.A., Hannigan A., O'Brien K.M. Mortality reductions due to mammography screening: Contemporary population-based data. PLoS One. 2017; 12(12): e0188947.
Kuhl C., Weigel S., Schrading S., Arand B., Bieling H., Konig R. et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J. Clin. Oncol. 2010; 28(9): 1450-7.
Berg W.A., Zhang Z., Lehrer D., Jong R.A., Pisano E.D., Barr R.G. et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012; 307(13): 1394-404.
Wanders J.O., Holland K., Veldhuis W.B., Mann R.M., Pijnappel R.M., Peeters P.H. et al. Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res. Treat. 2017; 162(1): 95-103.
- Refbacks are not listed
Контент доступен под лицензией Creative Commons Attribution 3.0 License.